CVRx (CVRX) Free Cash Flow (2020 - 2026)
CVRx's (CVRX) quarterly Free Cash Flow came in at -$12.3 million in Q1 2026, up 4.62% year-on-year from -$11.7 million in Q1 2025, and down 25.04% quarter-over-quarter from -$9.8 million in Q4 2025.
CVRx (CVRX) Free Cash Flow (2020 - 2026) Analysis & Trends
CVRx's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$12.3 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 4.62% year-over-year to -$12.3 million in Q1 2026; TTM through Mar 2026 was -$40.2 million, a 3.41% increase from a year earlier, with the FY2025 full-year figure at -$40.8 million, down 0.6% from the prior year.
- Free Cash Flow slipped to -$12.3 million in Q1 2026 per CVRX's latest filing, from -$9.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$8.0 million in Q4 2023 and bottomed at -$13.0 million in Q2 2023.
- The 5-year median for Free Cash Flow is -$10.4 million (2024), against an average of -$10.4 million.
- Across the five-year window, Free Cash Flow plunged 112.82% in 2022 and climbed 28.13% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$10.9 million in 2022, then rose by 26.67% to -$8.0 million in 2023, then slipped by 0.65% to -$8.1 million in 2024, then fell by 21.91% to -$9.8 million in 2025, then slipped by 25.04% to -$12.3 million in 2026.
- Per Business Quant, the three latest CVRX Free Cash Flow figures stand at -$12.3 million (Q1 2026), -$9.8 million (Q4 2025), and -$10.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -12.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.29 Mn |
| Mar 31, 2026 | -12.29 Mn |
| Dec 31, 2025 | -9.83 Mn |
| Dec 31, 2025 | -9.83 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Mar 31, 2025 | -12.88 Mn |
| Mar 31, 2025 | -12.88 Mn |
| Dec 31, 2024 | -8.06 Mn |
| Dec 31, 2024 | -8.06 Mn |
| Sep 30, 2024 | -10.45 Mn |
| Sep 30, 2024 | -10.45 Mn |
| Jun 30, 2024 | -10.19 Mn |
| Jun 30, 2024 | -10.19 Mn |
| Mar 31, 2024 | -11.81 Mn |
| Mar 31, 2024 | -11.81 Mn |
| Dec 31, 2023 | -8.01 Mn |
| Dec 31, 2023 | -8.01 Mn |